Literature DB >> 24100022

Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processing.

Cara L Wellman1, Marguerite Camp, V Morgan Jones, Kathryn P MacPherson, Jessica Ihne, Paul Fitzgerald, Mouna Maroun, Emily Drabant, Ryan Bogdan, Ahmad R Hariri, Andrew Holmes.   

Abstract

Serotonin is critical for shaping the development of neural circuits regulating emotion. Pet-1 (FEV-1) is an ETS-domain transcription factor essential for differentiation and forebrain targeting of serotonin neurons. Constitutive Pet-1 knockout (KO) causes major loss of serotonin neurons and forebrain serotonin availability, and behavioral abnormalities. We phenotyped Pet-1 KO mice for fear conditioning and extinction, and on a battery of assays for anxiety- and depression-related behaviors. Morphology of Golgi-stained neurons in basolateral amygdala (BLA) and prelimbic cortex was examined. Using human imaging genetics, a common variant (rs860573) in the PET-1 (FEV) gene was tested for effects on threat-related amygdala reactivity and psychopathology in 88 Asian-ancestry subjects. Pet-1 KO mice exhibited increased acquisition and expression of fear, and elevated fear recovery following extinction, relative to wild-type (WT). BLA dendrites of Pet-1 KO mice were significantly longer than in WT. Human PET-1 variation associated with differences in amygdala threat processing and psychopathology. This novel evidence for the role of Pet-1 in fear processing and dendritic organization of amygdala neurons and in human amygdala threat processing extends a growing literature demonstrating the influence of genetic variation in the serotonin system on emotional regulation via effects on structure and function of underlying corticolimbic circuitry.
© 2013.

Entities:  

Keywords:  5-HTT; BLA; Basolateral amygdala; EtOH; FEV; Fear conditioning; KO; Medial prefrontal cortex; PL; PTSD; Pet-1, FEV; Pheochromocytoma 12 ets; Serotonin; Tph2; basolateral amygdala; ethanol; knockout; posttraumatic stress disorder; prelimbic cortex; the serotonin transporter; tryptophan hydroxylase-2; ventromedial prefrontal cortex; vmPFC

Mesh:

Substances:

Year:  2013        PMID: 24100022      PMCID: PMC3932627          DOI: 10.1016/j.expneurol.2013.09.025

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  70 in total

1.  Mineralocorticoid receptor Iso/Val (rs5522) genotype moderates the association between previous childhood emotional neglect and amygdala reactivity.

Authors:  Ryan Bogdan; Douglas E Williamson; Ahmad R Hariri
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

Review 2.  The serotonin transporter gene-linked polymorphism and negative emotionality: placing single gene effects in the context of genetic background and environment.

Authors:  A Holmes; A R Hariri
Journal:  Genes Brain Behav       Date:  2003-12       Impact factor: 3.449

Review 3.  Neuronal circuits of fear extinction.

Authors:  Cyril Herry; Francesco Ferraguti; Nicolas Singewald; Johannes J Letzkus; Ingrid Ehrlich; Andreas Lüthi
Journal:  Eur J Neurosci       Date:  2010-02-11       Impact factor: 3.386

4.  Serotonin transporter polyadenylation polymorphism modulates the retention of fear extinction memory.

Authors:  Catherine A Hartley; Morgan C McKenna; Rabia Salman; Andrew Holmes; B J Casey; Elizabeth A Phelps; Charles E Glatt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-19       Impact factor: 11.205

Review 5.  Neurodevelopmental origins of depressive disorders.

Authors:  Mark S Ansorge; René Hen; Jay A Gingrich
Journal:  Curr Opin Pharmacol       Date:  2006-12-21       Impact factor: 5.547

6.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

7.  Comparison of dopamine D1 and D5 receptor knockout mice for cocaine locomotor sensitization.

Authors:  Rose-Marie Karlsson; Kathryn R Hefner; David R Sibley; Andrew Holmes
Journal:  Psychopharmacology (Berl)       Date:  2008-07-04       Impact factor: 4.530

8.  Genetic strain differences in learned fear inhibition associated with variation in neuroendocrine, autonomic, and amygdala dendritic phenotypes.

Authors:  Marguerite C Camp; Kathryn P Macpherson; Lauren Lederle; Carolyn Graybeal; Stefano Gaburro; Lauren M Debrouse; Jessica L Ihne; Javier A Bravo; Richard M O'Connor; Stephane Ciocchi; Cara L Wellman; Andreas Lüthi; John F Cryan; Nicolas Singewald; Andrew Holmes
Journal:  Neuropsychopharmacology       Date:  2012-02-15       Impact factor: 7.853

9.  Efficient replication of over 180 genetic associations with self-reported medical data.

Authors:  Joyce Y Tung; Chuong B Do; David A Hinds; Amy K Kiefer; J Michael Macpherson; Arnab B Chowdry; Uta Francke; Brian T Naughton; Joanna L Mountain; Anne Wojcicki; Nicholas Eriksson
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

Review 10.  Deconstruction of vulnerability to complex diseases: enhanced effect sizes and power of intermediate phenotypes.

Authors:  David Goldman; Francesca Ducci
Journal:  ScientificWorldJournal       Date:  2007-11-02
View more
  11 in total

1.  5-HT1B autoreceptors differentially modulate the expression of conditioned fear in a circuit-specific manner.

Authors:  Y Liu; M A Kelly; T J Sexton; J F Neumaier
Journal:  Neuroscience       Date:  2015-04-20       Impact factor: 3.590

Review 2.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

3.  Basal forebrain moderates the magnitude of task-dependent amygdala functional connectivity.

Authors:  Adam X Gorka; Annchen R Knodt; Ahmad R Hariri
Journal:  Soc Cogn Affect Neurosci       Date:  2014-05-19       Impact factor: 3.436

4.  Hypothalamic-pituitary-adrenal axis genetic variation and early stress moderates amygdala function.

Authors:  Christina R Di Iorio; Caitlin E Carey; Lindsay J Michalski; Nadia S Corral-Frias; Emily Drabant Conley; Ahmad R Hariri; Ryan Bogdan
Journal:  Psychoneuroendocrinology       Date:  2017-03-12       Impact factor: 4.905

Review 5.  Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression.

Authors:  Collin Challis; Olivier Berton
Journal:  ACS Chem Neurosci       Date:  2015-03-17       Impact factor: 4.418

Review 6.  The genetics of anxiety-related negative valence system traits.

Authors:  Jeanne E Savage; Chelsea Sawyers; Roxann Roberson-Nay; John M Hettema
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-05-19       Impact factor: 3.568

7.  Adult Brain Serotonin Deficiency Causes Hyperactivity, Circadian Disruption, and Elimination of Siestas.

Authors:  Meredith Sorenson Whitney; Ashley M Shemery; Alexandra M Yaw; Lauren J Donovan; J David Glass; Evan S Deneris
Journal:  J Neurosci       Date:  2016-09-21       Impact factor: 6.167

8.  Mice genetically depleted of brain serotonin do not display a depression-like behavioral phenotype.

Authors:  Mariana Angoa-Pérez; Michael J Kane; Denise I Briggs; Nieves Herrera-Mundo; Catherine E Sykes; Dina M Francescutti; Donald M Kuhn
Journal:  ACS Chem Neurosci       Date:  2014-08-12       Impact factor: 4.418

Review 9.  Imaging Genetics and Genomics in Psychiatry: A Critical Review of Progress and Potential.

Authors:  Ryan Bogdan; Betty Jo Salmeron; Caitlin E Carey; Arpana Agrawal; Vince D Calhoun; Hugh Garavan; Ahmad R Hariri; Andreas Heinz; Matthew N Hill; Andrew Holmes; Ned H Kalin; David Goldman
Journal:  Biol Psychiatry       Date:  2017-01-13       Impact factor: 13.382

10.  Postnatal maintenance of the 5-Ht1a-Pet1 autoregulatory loop by serotonin in the raphe nuclei of the brainstem.

Authors:  Ji-Young Kim; Ana Kim; Zhong-Qiu Zhao; Xian-Yu Liu; Zhou-Feng Chen
Journal:  Mol Brain       Date:  2014-06-28       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.